Prevalence of Metabolic Syndrome In Obese Patients Treated in an Internal Medicine Practice in Settat, Morocco
Mots-clés :
Diabetes mellitus, metabolic syndrome, obesity, Settat, MoroccoRésumé
Context:
Metabolic syndrome associates, in the same individual, several clinical and biological anomalies predisposing to cardiovascular risk and type 2 diabetes. Obesity exacerbates many of these characteristics.
Aims:
This study aimed to determine the prevalence of metabolic syndrome and its determinants in obese patients
Subjects and methods
This prospective study included 1459 obese patients treated from June 2009 to December 2023, at the Internal Medicine practice in Settat. metabolic syndrome was diagnosed according to the criteria NCEP ATP III (2002) and Consensus IDF and AHA / NHLBI (2009). criteria of the
Statistical analysis used:
The statistical analysis was carried out using SPSS software. Please mention the specific statistical tests used.
In the methodology I have detailed the statistical analysis. The summary should not be too long.
Results: please summarize the key findings more concisely.
The 1459 patients were aged 54.1 ± 11.2 years (30 to 90 years). The prevalence of metabolic syndrome was 60.3% according to NCEP III (2002) and 60.8% according to the Consensus (2009).Key criteria included high waist circumference (92.9% and 95.3%), blood pressure ≥ 130/85 mm Hg (70.8%), low HDL cholesterol (46.4%), a high triglyceride level (34.3%) and a blood sugar level ≥ 1.1 g / l or ≥ 1.0 g / l (32.1% and 35.6%).
The agreement between the two definitions was almost perfect. The prevalence was significantly higher in the elderly, diabetics and hypertensive patients. It was higher in grade 2 obesity (p = 0.001).
Conclusions:
The high prevalence of metabolic syndrome in this study suggests an increasing risk of cardiovascular morbidity and mortality. Systematic screaning and early intervention focusing on nutritional and physical activity modifications are essential
Téléchargements
Références
Magliano D.J, Boyko E.J, Balkau B, Barengo N, Barr E, Basit A, et al. Atlas du diabète de la Fédération Internationale du Diabète, Dixième édition, 2021.
Tazi MA, Abir-Khalil S, Chaouki N, Cherquaoui S, Lahmuz F, Srairi JE, et al. Prevalence of the main cardiovascular risk factors in Morocco: results of a national survey. Journal of Hypertension 2003;21:897-903.
DELM, Ministère de la Santé Maroc. Rapport de l’enquête nationale sur les facteurs de risque communs des maladies non transmissibles, Steps, 2017-2018.
Daphne PG, Wei Z, Nick B, Zubin A, C Laird Birmingham, Aslam HA. The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis. BMC Public Health 2009;9:88.
Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-16.
Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA, et al. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 2002;156:1070-7.
Meigs JB, Rutter MK, Sullivan LM, Fox CS, D'Agostino RB, Sr, Wilson PW. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome. Diabetes Care. 2007;30(5):1219-1225.
World Health Organization (1999) Diabetes and Non-Communicable Disease Risk Factor Surveys: A Field Guide. Geneva, World Health Org (WHO/NCD/NCS/99-1).
Third report of the national cholesterol education program. Evaluation and treatment of high blood cholesterol in adults ATP III final report. Circulation, 2002;106:3143-3421.
Einhorn D, Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 2003;9:237-252.
Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler ThrombVasc Biol 2004;24:e13-e18.
Alberti KG, Zimmet P, Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 2005;366:1059-1062.
Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the Metabolic Syndrome. A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention, National Heart Lung and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–1645.
Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension. Journal of Hypertension 2013;31:1281-1.
American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2006;29:S43-S48.
Ziegler O, Debry O. Epidémiologie des obésités de l’adulte. Encycl. Méd. Chir. (Elsevier, Paris). Endocrinologie – Nutrition, 10-506-B-20, 1998, 7 p.
World Health Organization. Obesity: prevention and management of the global epidemic. Report of a WHO consultation. Technical Report Series 2003;(894).
Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Almeras N, et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia, hyper apolipoprotein B, small dense LDL) in men? Circulation 2000;102:179-84.
Graphpad Software. Quick Calcs online calculators for scientists: quantify agreement with kappa [Internet]. Available from http://www.graphpad.com/quickcalcs/Kappa2.cfm./. Accessed 19 May 2010. Google Scholar
Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Himmelfarb CD, et al. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol2017;Nov 13:[Epub ahead of print].
Haut Commissariat au Plan : ENCDM 2000/2001, ENNVM 2006/2007et ENA.2011,
El Brini O, Benazzouz B, Gamal A, Mesfioui A, Akhouayri O. Prevalence of metabolic syndrome and its components based on a harmonious definition among adults in Morocco. DiabetesMetabSyndrObes2014;7,341-346.
Smaili W. Profil épidémiologique, clinique et thérapeutique du syndrome métabolique au sein du service de gastroentérologie. [Thèse]. Marrakech Université Quadi Ayad;2017.
Ajdi F, Elouahabi H, Agerd L, Safi S. Évaluation de la prévalence du syndrome métabolique chez une population atteinte de diabète de type 2. Diabetes & Metabolism. Volume 36, Supplement 1, March 2010, Page A47http://www.sciencedirect.com/science/article/pii/S1262363610701798.
Ellatifi R, Elmghari G, Elansari N, Amine M. P195 Effet du statut hormonal sur la survenue du syndrome métabolique chez la diabétique. March 2012. Diabetes & Metabolism 38(2):A77. 10.1016/S1262-3636(12)71297-1.
Tadmori A, Andzouana N, Agerd L, Ajdi F. Syndrome métabolique et néphropathie chez la population diabétique. CHU Hassan II, Fès, Maroc. Diabetes & Metabolism. March 2014 Volume 40, Supplement 1, Page A80.
El Aadmi M, Rostom S, Idrissi Z, Raissouni H, Benbouazza K, Hajjaj-Hassoun N. Prévalence du syndrome métabolique chez les patients atteints de polyarthrite rhumatoïde au Maroc et ses déterminants. SFR, Congrès 2010, Poster 138.
Berdi F. Syndrome métabolique et obésité étude prospective réalisée à l’hôpital Militaire d’Instruction Mohammed V. [Thèse]. Rabat Université Mohammed V ;2012.
Motaib I, Bennis S, El Mghari G, Elansari N. P276 Le syndrome métabolique et obésité, à propos de 120 cas Marrakech, Maroc. Diabetes & Metabolism Volume 40, n° S1 pages A92-A93 (mars 2014).
El Boukhrissi F, Bamou Y, Ouleghzal H, Balouch L. Prévalence des facteurs de risque des maladies cardiovasculaires et du syndrome métabolique chez les femmes de la région de Meknès, Maroc. Médecine des Maladies Métaboliques. March 2017;11(2):188-194.
Ford ES, Li C, Zhao G. Prévalence et corrélats du syndrome métabolique basés sur une définition harmonieuse chez les adultes aux États-Unis. J Diabetes. 2010;2:180–193.
Prasad DS, Kabir Z, Dash AK, Das BC. Prevalence and risk factors for metabolic syndrome in Asian Indians: A community study from urban Eastern India. J Cardiovasc Dis Res. 2012;3:204–211.
Motala AA, Esterhuizen T, Pirie FJ, Omar MA. Prevalence of metabolic syndrome and determination of the optimal waist circumference cutoff points in a rural South african community. Diabetes Care. 2011;34:1032–1037.
Gamila S, Dallongeville J. Épidémiologie du syndrome métabolique en France. Med Nutr2003:39, 89-94.
Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006 ; 444 :881-887.
Farnier M. Dyslipidémie de l’obésité abdominale : mécanismes et caractéristiques (partie I). Archives des maladies du coeur et des vaisseaux. 2007;(12):979-984.
Foucan L, Deloumeaux J, Donnet JP, Bangou J, Larifla L, Messerchmitt C, et al. Metabolic syndrome components in Indians migrants with type 2 diabetes subjects. A matched comparative study. Diabetes Diabetes Metab. 2006;32:337-42.
Farnier M, Le syndrome métabolique : quelle définition ? Quel risque ? Quelle attitude thérapeutique ? Correspondances en Risque CardioVasculaire - Vol. I - n° 1 - octobre-novembre-décembre 2003 ; 25-30
Azgaou I, El Mghari G, El Ansari N. Syndrome métabolique : quel rôle du tissu adipeux et quel traitement ? Feuillets de Biologie/N° 323 - Mars 2015.
Zeber J, Parchman ML. Cardiovascular disease in type 2 diabetes: Attributable risk due to modifiable risk factors. Can Fam Physician. 2010;56(8):302–307.
